Open Access<p>Upregulation of STC2 in colorectal cancer and its clinicopathological significance</p>
Author(s) -
Chunxiao Zhang,
Shuangqian Chen,
Xiang Ma,
Qian Yang,
Fei Su,
Xiang Shu,
Wei Xie,
Feng Mao,
Bin Xiong
Publication year - 2019
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s191609
Subject(s) - colorectal cancer , medicine , oncology , proportional hazards model , metastasis , survival analysis , clinical significance , multivariate analysis , cancer , biomarker , cancer research , biology , biochemistry
Stanniocalcin 2 (STC2) is a glycoprotein hormone involved in many biological processes and a secretory protein that regulates malignant tumor progression. The aim of the present study was to further explore the clinicopathological significance and prognostic role of STC2 in colorectal cancer (CRC).